China Life Insurance’s consensus price target has risen, primarily reflecting a notable increase in its Future P/E multiple while profitability, as measured by net margin, remained stable.
What's in the News
- Approved a final dividend of RMB 0.45 per share (HKD 0.49286 per share, inclusive of tax) for 2024, with entitlement and distribution details specified for H Shareholders.
- Removed from Shanghai Stock Exchange 180 Value Index.
Valuation Changes
Summary of Valuation Changes for China Life Insurance
- The Consensus Analyst Price Target has risen slightly from HK$19.71 to HK$20.14.
- The Future P/E for China Life Insurance has significantly risen from 8.17x to 9.12x.
- The Net Profit Margin for China Life Insurance remained effectively unchanged, at 10.04%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.